- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01652066
Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults (PROBIMMUNE)
Effect of a Mixture of Probiotics ( Lactobacillus Gasseri PA16/8,Bifidobacterium Longum SP07/3, Bifidobacterium Bifidum MF 20/5) on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adult
Study Overview
Status
Intervention / Treatment
Detailed Description
probiotics are "live microorganisms which when administered in adequate amounts confer a health benefit on the host" . many health effects are associated with probiotics , but various degrees of evidence support the benefits associated to probiotics consumption . Impact on defences and the immune system has been shown with several strains and this may result in improved protection against some infections or improvment of vaccine efficacy .
In its scientific requirments for health claims related to immune function, EFSA indicates that it is generally accepted that higher vaccination responses are beneficial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44200
- Biofortis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy male and female adult
- between 18 and 60 years old non menopausal female( with effective contraception)
- female non pregnant- not wishing to be pregnat during the study capable to respect the protocol
- affialted to the social security system aggreeing to be registered in the national fileof volunteers
Exclusion Criteria:
- food allergy( component of the experimental product- vaccines)
- manifestation of allergy
- vaccinated against flu during the 2 previous winters
- Food allergy, allergy to one of the component of the experimental products or allergy to one of the component of the flu vaccine;
- Subject displaying manifestation of allergy or being treated for these;
- Subject vaccinated against flu during the 2 previous winter (winter 2009-2010 and winter 2010-2011);
- Subject who had symptoms evocating flu during the previous winter (winter 2010-2011);
- Subject immunodepressed;
- Subject with immunomodulatory treatment;
- Subject who received a treatment resulting in systemic immunossuppression or local immunosuppression at pulmonary level, for at least 1 week during the last 3 months before inclusion (V1);
- Subject with auto-immune disease;
- Subject with inflammatory and chronic diseases;
- Subject with on-going antibiotics treatment at the time of the inclusion;
- Subject not agree to stop his/her usual probiotics supplementation during the study;
- Use of medication which could interfere with the study in the investigator's opinion (antibiotics, etc…);
- Any health condition for which the influenza vaccine is not recommended;
- Subject having received any other vaccine within one month prior to enrolment or intent to receive any other vaccination during the study period.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
oral consumption, once per day in the morning, fasting, with a glass of water
|
effect of the consumption a mixture of probiotics ( dietary supplement tablet - dosage at least 10x7 cfu/g) during 7 weeks , once a day , healthy volonteers ) on the antigen specific antibody respense
|
Experimental: Mixture of probiotics
at least 10x7 cfu/tablet of a mixture of probiotics oral consumption, once per day in the morning, fasting, with a glass of water |
effect of the consumption a mixture of probiotics ( dietary supplement tablet - dosage at least 10x7 cfu/g) during 7 weeks , once a day , healthy volonteers ) on the antigen specific antibody respense
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
geographic mean of the increase of antibody titreq against at least one flu strain among the 3 forming the flu vaccine ( H1N1, H3, N and B ) within 3 weeks after flu vaccination
Time Frame: inclusion-W 4-W 7
|
inclusion-W 4-W 7
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
seroprotection of the population of volunteers geometric mean of the increase of antibody titres seroprotection in the subset population non sero-protected at V1
Time Frame: inclusion- W4- W7
|
inclusion- W4- W7
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2011-A00225-36
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mixture of probitiocs
-
Laboratorios OrdesaUnknown
-
Ma JuanCompletedNeonatal Meconium AspirationChina
-
University of Texas Southwestern Medical CenterRecruitingObesity | Heart Failure With Preserved Ejection FractionUnited States
-
Biosearch S.A.RecruitingMild Cognitive ImpairmentSpain
-
Università degli Studi di BresciaCompletedDialysis | Uremia | Survival | Elderly (Aged >70) | Low Protein DietItaly
-
NestléCompletedHealthyNew Zealand
-
KU LeuvenCompletedStress | Emotions | FearBelgium
-
University of HelsinkiUnknownFood Hypersensitivity | Asthma | Atopic Dermatitis | Allergic Conjunctivitis | Allergic Rhinitis, SeasonalFinland
-
Mayo ClinicCompletedBidirectional Cardiovascular ShuntUnited States
-
China Medical University HospitalWithdrawnVery Low Birth Weight InfantsTaiwan